News and Press Releases
Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...
Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024
Asahi Kasei Bioprocess to Unveil THESYS ACS ERGO Synthesis Column at TIDES USA – offering reduced changeover time while maintaining safety and product quality
30 April 2024 -- Düsseldorf, Germany; Tokyo, Japan; and New York, US -- Generating cutting-edge therapeutics requires precision, safety and efficiency from manufacturing equipment. The next generation of oligo manufacturing,...
Category: BioManufacturing, Manufacturing and Packing
Posted: April 30, 2024
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...
Category: Biotechnology, Clinical Trials
Posted: April 3, 2024
Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence
28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...
Category: Biotechnology
Posted: March 28, 2024
SMC Ltd Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina, US
26 March 2024 -- Wisconsin, US -- SMC Ltd, the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility...
Category: Manufacturing and Packing
Posted: March 26, 2024
Recipharm attains major sustainability milestones
Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...
Category: Manufacturing and Packing
Posted: March 26, 2024
Gilbert To Officially Open New Development and GMP Manufacturing Facility
22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...
Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN
Viroclinics-DDL Changes Name to Cerba Research
14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...
Category: Biotechnology, Clinical Trials
Posted: March 15, 2024
Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings
Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring. Coriolis is now preparing for inspection by the competent surveillance authority for...
Category: Manufacturing and Packing
Posted: March 6, 2024
Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes
5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...
Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer
First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in phase 1b study in platinum-resistant ovarian cancer (PROC) patients scheduled...
Category: BioManufacturing
Posted: March 5, 2024
Kite Presents New Data for Yescarta (axicabtagene ciloleucel) CAR T-cell Therapy Highlighting Manufacturing Excellence and Cost-Effectiveness in the US
Data Highlights Industry-leading Manufacturing Success Rates for US Axicabtagene Ciloleucel Patients from Launch to Present Data Also Supports Cost-effectiveness of Axicabtagene Ciloleucel Versus Bispecific Antibodies 16 February 2024 – Stockley...
Category: BioManufacturing
Posted: February 21, 2024
Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park
20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...
Category: Manufacturing and Packing
Posted: February 20, 2024
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US
argenx Announces MHRA Licensing of Subcutaneous VYVGART (efgartigimod alfa) for generalised Myasthenia Gravis
VYVGART is now licensed for both intravenous (IV) and self-administered subcutaneous (SC) use in the UK 7 February 2024 -- Gerrards Cross, UK -- argenx UK, part of argenx, a...
Category: Biotechnology
Posted: February 7, 2024
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG
Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...
Category: Drug Delivery
Posted: January 23, 2024
